These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 21300751)
1. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. Miyazaki M; McCarthy JJ; Fedele MJ; Esser KA J Physiol; 2011 Apr; 589(Pt 7):1831-46. PubMed ID: 21300751 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. Moore SF; Hunter RW; Hers I J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393 [TBL] [Abstract][Full Text] [Related]
3. No role for early IGF-1 signalling in stimulating acute 'muscle building' responses. Burd NA; West DW; Camera DM; Breen L J Physiol; 2011 Jun; 589(Pt 11):2667-8. PubMed ID: 21632529 [No Abstract] [Full Text] [Related]
4. ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling. Winter JN; Jefferson LS; Kimball SR Am J Physiol Cell Physiol; 2011 May; 300(5):C1172-80. PubMed ID: 21289294 [TBL] [Abstract][Full Text] [Related]
5. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK; Pizzo SV PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152 [TBL] [Abstract][Full Text] [Related]
6. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358 [TBL] [Abstract][Full Text] [Related]
7. Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. Kazyken D; Lentz SI; Wadley M; Fingar DC J Biol Chem; 2023 Sep; 299(9):105097. PubMed ID: 37507012 [TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle. Ferey JL; Brault JJ; Smith CA; Witczak CA Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E686-94. PubMed ID: 25159322 [TBL] [Abstract][Full Text] [Related]
9. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells. Yuen HF; Abramczyk O; Montgomery G; Chan KK; Huang YH; Sasazuki T; Shirasawa S; Gopesh S; Chan KW; Fennell D; Janne P; El-Tanani M; Murray JT Biosci Rep; 2012 Aug; 32(4):413-22. PubMed ID: 22668349 [TBL] [Abstract][Full Text] [Related]
15. Electrostimulation during hindlimb unloading modulates PI3K-AKT downstream targets without preventing soleus atrophy and restores slow phenotype through ERK. Dupont E; Cieniewski-Bernard C; Bastide B; Stevens L Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R408-17. PubMed ID: 21106911 [TBL] [Abstract][Full Text] [Related]
16. Renal tumours in a Tsc2(+/-) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Yang J; Kalogerou M; Samsel PA; Zhang Y; Griffiths DF; Gallacher J; Sampson JR; Shen MH Oncogene; 2015 Feb; 34(7):922-31. PubMed ID: 24632604 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells. Nishimura Y; Chunthorng-Orn J; Lord S; Musa I; Dawson P; Holm L; Lai YC Am J Physiol Cell Physiol; 2022 Jul; 323(1):C215-C225. PubMed ID: 35704697 [TBL] [Abstract][Full Text] [Related]
18. Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes. Hong-Brown LQ; Brown CR; Navaratnarajah M; Lang CH Alcohol Clin Exp Res; 2013 Nov; 37(11):1849-61. PubMed ID: 23895284 [TBL] [Abstract][Full Text] [Related]
19. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα). Dan HC; Ebbs A; Pasparakis M; Van Dyke T; Basseres DS; Baldwin AS J Biol Chem; 2014 Sep; 289(36):25227-40. PubMed ID: 24990947 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice. Shum M; Bellmann K; St-Pierre P; Marette A Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]